Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors

Rawla, Prashanth, Sunkara, Tagore, Gaduputi, Vinaya·2019·World Journal of Oncology

Cited by (1,002)

Items 101–200 of 1,002

  1. High‐Throughput Single‐Cell Mass Spectrometry Reveals Abnormal Lipid Metabolism in Pancreatic Ductal Adenocarcinoma
    Qinlei Liu, Wenjie Ge, Tongtong Wang, Jiayi Lan, Sandra Martínez‐Jarquín, Christian Wolfrum, Markus Stoffel, Renato Zenobi · 2021 · Angewandte Chemie International Edition
  2. The Sex Bias of Cancer
    Ana Raquel Costa, Mariana Lança de Oliveira, Inés Seoane Cruz, Isabel Gonçalves, José Francisco Cascalheira, Cecília R.A. Santos · 2020 · Trends in Endocrinology and Metabolism
  3. Hadron Therapy, Magnetic Nanoparticles and Hyperthermia: A Promising Combined Tool for Pancreatic Cancer Treatment
    Francesca Brero, Martin Albino, Antonio Antoccia, Paolo Arosio, Matteo Avolio, Francesco Berardinelli, D. Bettega, Paola Calzolari, Mario Ciocca, M. Corti et al. · 2020 · Nanomaterials
  4. The Effect of Resveratrol and Quercetin on Epithelial-Mesenchymal Transition in Pancreatic Cancer Stem Cell
    Mustafa Hoca, Eda Becer, Hilal Kabadayı, Sevinç Yücecan, Seda Vatansever · 2019 · Nutrition and Cancer
  5. Artificial Intelligence-Driven Diagnosis of Pancreatic Cancer
    Bahrudeen Shahul Hameed, Uma Maheswari Krishnan · 2022 · Cancers
  6. Dual Tumor Exosome Biomarker Co-recognitions Based Nanoliquid Biopsy for the Accurate Early Diagnosis of Pancreatic Cancer
    Zhiguo Yu, Yang� Yang, Wenming Fang, Ping Hu, Yingbin Liu, Jianlin Shi · 2023 · ACS Nano
  7. Nucleotide metabolism in cancer cells fuels a UDP-driven macrophage cross-talk, promoting immunosuppression and immunotherapy resistance
    Tommaso Scolaro, Marta Manco, Mathieu Pecqueux, Ricardo Amorim, Rosa Trotta, Heleen H. Van Acker, Matthias Van Haele, Niranjan Shirgaonkar, Stefan Naulaerts, Jan Daniluk et al. · 2024 · Nature Cancer
  8. Randomized Phase II Trial Evaluating Two Sequential Treatments in First Line of Metastatic Pancreatic Cancer: Results of the PANOPTIMOX-PRODIGE 35 Trial
    Laëtitia Dahan, Nicolas Williet, Karine Le Malicot, Jean–Marc Phelip, Jérôme Desrame, Olivier Bouché, Caroline Pétorin, David Malka, Christine Rebischung, Thomas Aparicio et al. · 2021 · Journal of Clinical Oncology
  9. Developing effective combination therapy for pancreatic cancer: An overview
    Aubrey Lynn Miller, Patrick L. Garcia, Karina Jin Yoon · 2020 · Pharmacological Research
  10. Nanoprobe-Based Magnetic Resonance Imaging of Hypoxia Predicts Responses to Radiotherapy, Immunotherapy, and Sensitizing Treatments in Pancreatic Tumors
    Jing Liu, Horacio Cabral, Bin Song, Ichio Aoki, Zhouyun Chen, Nobuhiro Nishiyama, Yuan Huang, Kazunori Kataoka, Peng Mi · 2021 · ACS Nano
  11. The Role of Stellate Cells in Pancreatic Ductal Adenocarcinoma: Targeting Perspectives
    Yang Feng Wu, Chun Zhang, Kuirong Jiang, Jens Martin Werner, Alexandr V. Bazhin, Jan Goesta D’Haese · 2021 · Frontiers in Oncology
  12. Unravelling the enigma of siRNA and aptamer mediated therapies against pancreatic cancer
    Zhe Liu, Neha Parveen, Urushi Rehman, Aisha Aziz, Afsana Sheikh, Mohammed A. S. Abourehab, Wei Guo, Junhao Huang, Zhenning Wang, Prashant Kesharwani · 2023 · Molecular Cancer
  13. Oral bacteria accelerate pancreatic cancer development in mice
    Elias Saba, Maria Farhat, Alaa Daoud, Arin Khashan, Esther Forkush, Noam Hallel Menahem, Hasnaa Makkawi, Karthikeyan Pandi, Sarah Angabo, Hiromichi Kawasaki et al. · 2024 · Gut
  14. A Role for the WNT Co-Receptor LRP6 in Pathogenesis and Therapy of Epithelial Cancers
    Jennifer Raisch, Anthony Côté-Biron, Nathalie Rivard · 2019 · Cancers
  15. Cuproptosis-related gene index: A predictor for pancreatic cancer prognosis, immunotherapy efficacy, and chemosensitivity
    Xu‐Feng Huang, Shujing Zhou, Ying Liu, J Tóth, Hajdu András · 2022 · Frontiers in Immunology
  16. Tumor organoid biobank-new platform for medical research
    Xuexue Xie, Xinyu Li, Wei Song · 2023 · Scientific Reports
  17. An updated review of the H19 lncRNA in human cancer: molecular mechanism and diagnostic and therapeutic importance
    Behnam Alipoor, Seyedeh Nasrin Parvar, Zolfaghar Sabati, Hamid Ghaedi, Hassan Ghasemi · 2020 · Molecular Biology Reports
  18. Genetic characteristics and prognostic implications of m1A regulators in pancreatic cancer
    Qingyuan Zheng, Xiao Yu, Qiyao Zhang, Yuting He, Wenzhi Guo · 2021 · Bioscience Reports
  19. Oncobiosis and Microbial Metabolite Signaling in Pancreatic Adenocarcinoma
    Borbála Kiss, Edit Mikó, Éva Sebő, Judit Tóth, Gyula Ujlaki, Judit Szabó, Karen Uray, Péter Bai, Péter Árkosy · 2020 · Cancers
  20. Epithelial to Mesenchymal Transition: Key Regulator of Pancreatic Ductal Adenocarcinoma Progression and Chemoresistance
    Kostas Palamaris, Evangelos S. Felekouras, Stratigoula Sakellariou · 2021 · Cancers
  21. Pancreatic Cancer: Challenges and Opportunities in Locoregional Therapies
    Alaa Y. Bazeed, Candace Minhthu Day, Sanjay Garg · 2022 · Cancers
  22. Bioactive compounds, antioxidant capacity and antitumoral activity of ethanolic extracts from fruits and seeds of Eugenia involucrata DC
    Julheli R. Girardelo, Eduarda Laís Munari, Julio Cesar Sbardella Dallorsoleta, Gustavo Godinho Cechinel, André Lucio Fontana Goetten, Luziane Ramos Sales, Flávio Henrique Reginatto, Vítor Clasen Chaves, Franciele Aline Smaniotto, Sabrina Somacal et al. · 2020 · Food Research International
  23. Recent Discoveries of Diagnostic, Prognostic and Predictive Biomarkers for Pancreatic Cancer
    Andrii Khomiak, Marius Brunner, Maximilian Kordes, Stina Lindblad, Rainer Christoph Miksch, Daniel Öhlund, Ivonne Regel · 2020 · Cancers
  24. Combining CD40 agonist mitazalimab with mFOLFIRINOX in previously untreated metastatic pancreatic ductal adenocarcinoma (OPTIMIZE-1): a single-arm, multicentre phase 1b/2 study
    Jean–Luc Van Laethem, Ivan Borbath, Hans Prenen, Karen Geboes, Aurélien Lambert, Emmanuel Mitry, Philippe Alexandre Cassier, Jean‐Frédéric Blanc, Lorenzo Pilla, Jaime Feliú et al. · 2024 · The Lancet Oncology
  25. A Single‐Molecule Bioelectronic Portable Array for Early Diagnosis of Pancreatic Cancer Precursors
    Enrico Genco, Francesco Modena, Lucia Sarcina, Kim Björkström, Celestino Brunetti, Mario Caironi, Mariapia Caputo, Virginia Maria Demartis, Cinzia Di Franco, Giulia Frusconi et al. · 2023 · Advanced Materials
  26. Bitter apricot ethanolic extract induces apoptosis through increasing expression of Bax/Bcl-2 ratio and caspase-3 in PANC-1 pancreatic cancer cells
    Fatemeh Aamazadeh, Alireza Ostadrahimi, Yalda Rahbar Saadat, Jaleh Barar · 2020 · Molecular Biology Reports
  27. Engineering Chimeric Antigen Receptor T Cells against Immune Checkpoint Inhibitors PD-1/PD-L1 for Treating Pancreatic Cancer
    Ching‐Yao Yang, Ming Huei Fan, Carol H. Miao, Yi‐Jen Liao, Ray‐Hwang Yuan, Chao-Lien Liu · 2020 · Molecular Therapy — Oncolytics
  28. Metabolic syndrome and risk of pancreatic cancer: A population‐based prospective cohort study
    Bin Xia, Qiangsheng He, Yihang Pan, Fang Gao, Anran Liu, Yan Tang, Charing C. N. Chong, Anthony Y. Teoh, Fangping Li, Yulong He et al. · 2020 · International Journal of Cancer
  29. Targeting Redox Metabolism in Pancreatic Cancer
    Nadine Abdel Hadi, Gabriela Reyes‐Castellanos, Alice Carrier · 2021 · International Journal of Molecular Sciences
  30. The oral microbiome, pancreatic cancer and human diversity in the age of precision medicine
    Kelly M. Herremans, Andrea N. Riner, Miles E. Cameron, Kelley Lobean McKinley, Eric W. Triplett, Steven J. Hughes, Jose Gilberto Trevino · 2022 · Microbiome
  31. Molecular profile of metastasis, cell plasticity and EMT in pancreatic cancer: a pre-clinical connection to aggressiveness and drug resistance
    Zhenli Guo, Milad Ashrafizadeh, Wei Zhang, Rongjun Zou, Gautam Sethi, Xianbin Zhang · 2023 · Cancer and Metastasis Reviews
  32. LncRNA NEAT1 facilitates pancreatic cancer growth and metastasis through stabilizing ELF3 mRNA.
    Yaguang Feng, Ling Gao, Guangfei Cui, Yan Wei Cao · 2020 · PubMed Central
  33. Prostate cancer-derived exosomes promote osteoblast differentiation and activity through phospholipase D2
    Mathieu Borel, Giovanna Lollo, David Magne, René Buchet, Leyre Brizuela, Saïda Mebarek · 2020 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  34. Fisetin, a Potent Anticancer Flavonol Exhibiting Cytotoxic Activity against Neoplastic Malignant Cells and Cancerous Conditions: A Scoping, Comprehensive Review
    Robert Kubina, Kamil Krzykawski, Agata Kabała‐Dzik, Robert Dariusz Wojtyczka, Ewa Chodurek, Arkadiusz Marian Dziedzic · 2022 · Nutrients
  35. Pectin-Tannic Acid Nano-Complexes Promote the Delivery and Bioactivity of Drugs in Pancreatic Cancer Cells
    Sumeet S. Chauhan, Advait B. Shetty, Elham Hatami, Pallabita Chowdhury, Murali Mohan Yallapu · 2020 · Pharmaceutics
  36. Remediating Desmoplasia with EGFR‐Targeted Photoactivable Multi‐Inhibitor Liposomes Doubles Overall Survival in Pancreatic Cancer
    Girgis Obaid, Shazia Bano, Hanna Thomsen, Susan Callaghan, Nimit Shah, Joseph W. R. Swain, Wendong Jin, Xiadong Ding, Colin G. Cameron, Sherri A. McFarland et al. · 2022 · Advanced Science
  37. Microbiome as a biomarker and therapeutic target in pancreatic cancer
    Ghazaleh Pourali, Danial Kazemi, Amir Shayan Chadeganipour, Mahshid Arastonejad, Sara Naghizadeh Kashani, Roozbeh Pourali, Mina Maftooh, Hamed Akbarzade, Hamid Fiuji, Seyed Mahdi Hassanian et al. · 2024 · BMC Microbiology
  38. Validation of the Enriching New-Onset Diabetes for Pancreatic Cancer Model in a Diverse and Integrated Healthcare Setting
    Wansu Chen, Rebecca K. Butler, Eva Lustigova, Suresh T. Chari, Bechien U. Wu · 2020 · Digestive Diseases and Sciences
  39. Checking NEKs: Overcoming a Bottleneck in Human Diseases
    Andressa Peres de Oliveira, Luidy Kazuo Issayama, Isadora Carolina Betim Pavan, Fernando Riback Silva, Talita Diniz Melo‐Hanchuk, Fernando Moreira Simabuco, Jörg Kobarg · 2020 · Molecules
  40. The plasticity of pancreatic cancer stem cells: implications in therapeutic resistance
    Kalyani Patil, Khan Farheen Badrealam, Sabah Akhtar, Aamir Ahmad, Shahab Uddin M.S. · 2021 · Cancer and Metastasis Reviews
  41. Newly Developed Targeted Therapies Against the Androgen Receptor in Triple-Negative Breast Cancer: A Review
    Edris Choupani, Mohammad Mahmoudi Gomari, Saeed Zanganeh, Sherko Nasseri, Kaveh Haji-Allahverdipoor, Neda Rostami, Yaeren Hernandez, Safa Najafi, Neda Saraygord‐Afshari, Arshad Hosseini · 2022 · Pharmacological Reviews
  42. Establishing a living biobank of patient-derived organoids of intraductal papillary mucinous neoplasms of the pancreas
    Francisca Beato, Dayana Reverón, Kaleena B. Dezsi, Antonio C. Ortiz, Joseph Johnson, Dung‐Tsa Chen, Karla N. Ali, Sean Yoder, Daniel K. Jeong, Mokenge Peter Malafa et al. · 2020 · Laboratory Investigation
  43. Adjuvant and neoadjuvant treatment for pancreatic adenocarcinoma
    Fuyuhiko Motoi, Michiaki Unno · 2020 · Japanese Journal of Clinical Oncology
  44. Treatment of metastatic pancreatic cancer: 25 years of innovation with little progress for patients
    Bishal Gyawali, Christopher M. Booth · 2024 · The Lancet Oncology
  45. Targeted Nanoparticle-Based Diagnostic and Treatment Options for Pancreatic Cancer
    Xin Gu, Tamara Minko · 2024 · Cancers
  46. Expression Profiling of Circulating Tumor Cells in Pancreatic Ductal Adenocarcinoma Patients: Biomarkers Predicting Overall Survival
    Consuelo Amantini, Maria Beatrice Morelli, Massimo Nabissi, Francesco Piva, Oliviero Marinelli, Federica Maggi, Francesca Bianchi, Alessandro Bittoni, Rossana Berardi, Riccardo Giampieri et al. · 2019 · Frontiers in Oncology
  47. The Effects of Capsaicin on Gastrointestinal Cancers
    George Denis Alexandru Popescu, Cristian Scheau, Ioana Anca Bădărău, Mihai-Daniel Dumitrache, Ana Căruntu, Andreea-Elena Scheau, Daniel Octavian Costache, Raluca Simona Costache, Carolina Constantin, Monica Teodora Neagu et al. · 2020 · Molecules
  48. Tumor immune microenvironment in pancreatic ductal adenocarcinoma revisited – Exploring the “Space”
    Konstantin Bräutigam, Kristijan Skok, K Szymoński, Charlotte Vestrup Rift, Eva Karamitopoulou · 2025 · Cancer Letters
  49. Acinar cell clonal expansion in pancreas homeostasis and carcinogenesis
    Patrick Neuhöfer, Caitlin M. Roake, Stewart J. Kim, Ryan J. Lu, Robert B. West, Gregory W. Charville, Steven E. Artandi · 2021 · Nature
  50. Analysis of the fractional tumour-immune-vitamins model with Mittag–Leffler kernel
    Shabir Ahmad, Aman Ullah, Ali Akgül, Dumitru Bǎleanu · 2020 · Results in Physics
  51. Correlation between drug sensitivity profiles of circulating tumour cell-derived organoids and clinical treatment response in patients with pancreatic ductal adenocarcinoma
    Yuan‐Hung Wu, Yi‐Ping Hung, Nai‐Chi Chiu, Rheun‐Chuan Lee, Chung‐Pin Li, Yee Chao, Yi‐Ming Shyr, Shin‐E Wang, Shih‐Chin Chen, Sheng‐Hsuan Lin et al. · 2022 · European Journal of Cancer
  52. Arterial resections in pancreatic cancer – Systematic review and meta-analysis
    Piotr Małczak, Marek Sierżęga, Tomasz Stefura, Artur Kacprzyk, Jakub Droś, Oksana Skomarovska, Marta Krzysztofik, Piotr Major, Michał Pędziwiatr · 2020 · HPB
  53. Carbon ion radiotherapy in pancreatic cancer: A review of clinical data
    Jakob Liermann, Makoto Shinoto, Mustafa Syed, Jürgen Debus, Klaus K Herfarth, Patrick Naumann · 2020 · Radiotherapy and Oncology
  54. Short‐Bowel Syndrome: Epidemiology, Hospitalization Trends, In‐Hospital Mortality, and Healthcare Utilization
    Mohamed Tausif Siddiqui, Wael A. Al-Yaman, Amandeep Singh, Donald F. Kirby · 2020 · Journal of Parenteral and Enteral Nutrition
  55. NF-κB and Pancreatic Cancer; Chapter and Verse
    John Silke, Lorraine Ann O’Reilly · 2021 · Cancers
  56. Exocrine-Endocrine Crosstalk: The Influence of Pancreatic Cellular Communications on Organ Growth, Function and Disease
    Danielle L. Overton, Teresa L. Mastracci · 2022 · Frontiers in Endocrinology
  57. Cyclodextrin nanoparticles for diagnosis and potential cancer therapy: A systematic review
    Anandakrishnan Karthic, Arpita Roy, Jaya Lakkakula, Saad Ali Alghamdi, Afnan Mohammed Shakoori, Ahmad O. Babalghith, Talha Bin Emran, Rohit Sharma, Clara Mariana Gonçalves Lima, Bonglee Kim et al. · 2022 · Frontiers in Cell and Developmental Biology
  58. Syk Inhibition Reprograms Tumor-Associated Macrophages and Overcomes Gemcitabine-Induced Immunosuppression in Pancreatic Ductal Adenocarcinoma
    Deepak Rohila, In Hwan Park, Timothy V. Pham, Jonathan Weitz, Tatiana Hurtado de Mendoza, Suresh Madheswaran, Mehreen Ishfaq, Cooper Beaman, Elisabette Tapia, Siming Sun et al. · 2023 · Cancer Research
  59. Pancreatic stellate cells activated by mutant KRAS-mediated PAI-1 upregulation foster pancreatic cancer progression via IL-8
    Hao‐Chen Wang, Yung-Lun Lin, Ching-Cheng Hsu, Ying‐Jui Chao, Ya‐Chin Hou, Tai‐Jan Chiu, Po-Hsien Huang, Ming‐Jer Tang, Li‐Tzong Chen, Yan‐Shen Shan · 2019 · Theranostics
  60. PTHrP Drives Pancreatic Cancer Growth and Metastasis and Reveals a New Therapeutic Vulnerability
    Jason Robert Pitarresi, Robert J. Norgard, Anna M. Chiarella, Kensuke Suzuki, Basil S. Bakir, Varun Sahu, Jinyang Li, Jun Zhao, Benoît Marchand, Maximilian D. Wengyn et al. · 2021 · Cancer Discovery
  61. Glucagon-like peptide-1 receptor agonists and pancreatic cancer risk: target trial emulation using real-world data
    Wang, Lindsey, Wang, QuanQiu, Li, Li, Kaelber, David C, Xu, Rong · 2025 · JNCI: Journal of the National Cancer Institute
  62. The interactive role of inflammatory mediators and metabolic reprogramming in pancreatic cancer
    Yuuki Ohara, Paloma Valenzuela, S. Perwez Hussain · 2022 · Trends in cancer
  63. Current Status of the Diagnosis of Early-Stage Pancreatic Ductal Adenocarcinoma
    Kazunori Nakaoka, Eizaburo Ohno, Naoto Kawabe, Teiji Kuzuya, Kohei Funasaka, Yoshihito Nakagawa, Mitsuo Nagasaka, Takuya Ishikawa, Ayako Watanabe, Takumi Tochio et al. · 2023 · Diagnostics
  64. Advances in pancreatic cancer early diagnosis, prevention, and treatment: The past, the present, and the future
    Alessandro Mannucci, Ajay Goel · 2025 · CA A Cancer Journal for Clinicians
  65. Combined Spiral Transformation and Model-Driven Multi-Modal Deep Learning Scheme for Automatic Prediction of TP53 Mutation in Pancreatic Cancer
    Xiahan Chen, Xiaozhu Lin, Qing Shen, Xiaohua Qian · 2020 · IEEE Transactions on Medical Imaging
  66. Annexin A1 Expression Is Associated with Epithelial–Mesenchymal Transition (EMT), Cell Proliferation, Prognosis, and Drug Response in Pancreatic Cancer
    Masanori Oshi, Yoshihisa Tokumaru, Swagoto Mukhopadhyay, Li Yan, Ryusei Matsuyama, Itaru Endo, Kazuaki Takabe · 2021 · Cells
  67. Targeting Fibrosis: The Bridge That Connects Pancreatitis and Pancreatic Cancer
    Can Huang, Juan Iovanna, Patricia Santofimia‐Castaño · 2021 · International Journal of Molecular Sciences
  68. Clostridium butyricum and its metabolite butyrate promote ferroptosis susceptibility in pancreatic ductal adenocarcinoma
    Xiaotong Yang, Zhengyan Zhang, Xuqing Shen, Junyi Xu, Yawen Weng, Wei Wang, Jing Xue · 2023 · Cellular Oncology
  69. The arginine metabolism and its deprivation in cancer therapy
    Tiejun Feng, Fuda Xie, Yang Lyu, Peiyao Yu, Bonan Chen, Jun Yu, Ge Zhang, Ka Fai To, Chi Man Tsang, Wei Kang · 2025 · Cancer Letters
  70. Understanding the immune landscape and tumor microenvironment of pancreatic cancer to improve immunotherapy
    Robert J. Torphy, Richard David Schulick, Yuwen Zhu · 2020 · Molecular Carcinogenesis
  71. Challenging biliary strictures: pathophysiological features, differential diagnosis, diagnostic algorithms, and new clinically relevant biomarkers - part 1
    Jean‐Marc Dumonceau, Myriam Delhaye, Nicolas Charette, Annarita Farina · 2020 · Therapeutic Advances in Gastroenterology
  72. Immune Cell Modulation of the Extracellular Matrix Contributes to the Pathogenesis of Pancreatic Cancer
    Ramiz S. Ahmad, Timothy D. Eubank, Sławomir Łukomski, Brian A. Boone · 2021 · Biomolecules
  73. EGR1 induces EMT in pancreatic cancer via a P300/SNAI2 pathway
    Yuanyang Wang, Cheng‐Feng Qin, Bangbo Zhao, Zeru Li, Tianyu Li, Xiaoying Yang, Yutong Zhao, Weibin Wang · 2023 · Journal of Translational Medicine
  74. Epidemiology of pancreatic cancer: New version, new vision
    Wenhao Luo, Jun Wang, Hao Chen, Liyuan Ye, Jiangdong Qiu, Yueze Liu, Ruobing Wang, Guihu Weng, Tao Liu, Dan Su et al. · 2023 · Chinese Journal of Cancer Research
  75. Antiplatelet Drug Ticagrelor Enhances Chemotherapeutic Efficacy by Targeting the Novel P2Y12-AKT Pathway in Pancreatic Cancer Cells
    Omar Elaskalani, Alice Domenichini, Norbaini Binti Abdol Razak, Danielle E. Dye, Marco Falasca, Pat Metharom · 2020 · Cancers
  76. GINS2 promotes EMT in pancreatic cancer via specifically stimulating ERK/MAPK signaling
    Longping Huang, Si Chen, Haijun Fan, Dawei Ji, Chuanping Chen, Weiwei Sheng · 2020 · Cancer Gene Therapy
  77. Polydopamine-gold composite-based electrochemical biosensor using dual-amplification strategy for detecting pancreatic cancer-associated microRNA
    SSu-Chia Chen, Kuan‐Ting Chen, Amily Fang‐Ju Jou · 2020 · Biosensors and Bioelectronics
  78. Clinical Analysis of Early-Stage Pancreatic Cancer and Proposal for a New Diagnostic Algorithm: A Multicenter Observational Study
    Juri Ikemoto, Masahiro Serikawa, Keiji Hanada, Noriaki Eguchi, Tamito Sasaki, Yoshifumi Fujimoto, Shinichiro Sugiyama, Atsushi Yamaguchi, Bunjiro Noma, Michihiro Kamigaki et al. · 2021 · Diagnostics
  79. The role of metabolic reprogramming in pancreatic cancer chemoresistance
    Chang Liu, Changfeng Li, Yuanda Liu · 2023 · Frontiers in Pharmacology
  80. Comparison between FOLFIRINOX and gemcitabine plus nab-paclitaxel including sequential treatment for metastatic pancreatic cancer: a propensity score matching approach
    Jung Won Chun, Sang Hyub Lee, Joo Seong Kim, Namyoung Park, Gunn Huh, In Rae Cho, Woo Hyun Paik, Ji Kon Ryu, Yong‐Tae Kim · 2021 · BMC Cancer
  81. A systematic review and meta-analysis of the association between circulating tumor DNA (ctDNA) and prognosis in pancreatic cancer
    Deniz Can Güven, Taha Koray Şahin, Hasan Çagri Yildirim, Oktay Halit Aktepe, Ömer Dızdar, Şuayib Yalçın · 2021 · Critical Reviews in Oncology/Hematology
  82. Lactobacillus casei combined with Lactobacillus reuteri alleviate pancreatic cancer by inhibiting TLR4 to promote macrophage M1 polarization and regulate gut microbial homeostasis
    Zemin Zhu, Bo Yi, Z Tang, Xun Chen, Ming Li, Tao Xu, Zhijian Zhao, Caixi Tang · 2023 · BMC Cancer
  83. Unraveling the Burden of Pancreatic Cancer in the 21st Century: Trends in Incidence, Mortality, Survival, and Key Contributing Factors
    Jakob Zottl, Christian Sebesta, Elena Tomosel, Marie Christine Sebesta, Christian Sebesta · 2025 · Cancers
  84. Epidemiology and Risk Factors of Pancreatic Cancer
    Michele Molinari, Hao Liu, Christof Kaltenmeier · 2023 · IntechOpen eBooks
  85. Dynamic profiling of immune microenvironment during pancreatic cancer development suggests early intervention and combination strategy of immunotherapy
    Jiaqi Yang, Qi Zhang, Junli Wang, Yu Lou, Zhengtao Hong, Shumei Wei, Ke Sun, Jianing Wang, Yiwen Chen, Jianpeng Sheng et al. · 2022 · EBioMedicine
  86. RHOF promotes Snail1 lactylation by enhancing PKM2-mediated glycolysis to induce pancreatic cancer cell endothelial–mesenchymal transition
    Rui Zhao, Yanmin Yi, Han Liu, Jianwei Xu, Shuhai Chen, Dong Wu, Lei Wang, Feng Li · 2024 · Cancer & Metabolism
  87. Genetically Engineered Pigs to Study Cancer
    Daniela Kalla, Alexander Kind, Angelika Schnieke · 2020 · International Journal of Molecular Sciences
  88. miR-802 Suppresses Acinar-to-Ductal Reprogramming During Early Pancreatitis and Pancreatic Carcinogenesis
    Wenjie Ge, Algera Goga, Yuliang He, Pamuditha N. Silva, Christian Hirt, Karolin Herrmanns, Ilaria Guccini, Svenja Godbersen, Gerald Schwank, Markus Stoffel · 2021 · Gastroenterology
  89. Small extracellular vesicles (exosomes) and their cargo in pancreatic cancer: Key roles in the hallmarks of cancer
    Lily M. Channon, Victoria M. Tyma, Zhihong Xu, David W. Greening, Jeremy S. Wilson, Chamini Jayamali Perera, Minoti Vivek Apte · 2022 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  90. The Urokinase Plasminogen Activation System in Pancreatic Cancer: Prospective Diagnostic and Therapeutic Targets
    Ashna A. Kumar, Benjamin J. Buckley, Marie Ranson · 2022 · Biomolecules
  91. Prognostic value of systemic immune-inflammation index in patients with pancreatic cancer: a meta-analysis
    Li Mao, Zhenlu Li, Zihe Wang, Chao Yue, Weiming Hu, Huimin Lü · 2022 · Clinical and Experimental Medicine
  92. Next-generation therapies for pancreatic cancer
    Conor W. Buckley, Eileen Mary O'Reilly · 2024 · Expert Review of Gastroenterology & Hepatology
  93. A randomized trial of pharmacological ascorbate, gemcitabine, and nab-paclitaxel for metastatic pancreatic cancer
    Kellie L. Bodeker, Brian J. Smith, Daniel Berg, Chandrikha Chandrasekharan, Saima Sharif, Naomi H. Fei, Sandy Vollstedt, Heather Brown, Meghan L. Chandler, Amanda C. Lorack et al. · 2024 · Redox Biology
  94. Global, regional, and national survey on the burden and quality of care of pancreatic cancer: a systematic analysis for the Global Burden of Disease study 1990–2017
    Armin Aryannejad, Mohammadreza Tabary, Narges Ebrahimi, Esmaeil Mohammadi, Nima Fattahi, Shahin Roshani, Masoud Masinaei, Shohreh Naderimagham, Sina Azadnajafabad, Kosar Jamshidi et al. · 2021 · Pancreatology
  95. Performance of deep learning for differentiating pancreatic diseases on contrast-enhanced magnetic resonance imaging: A preliminary study
    Xuchen Gao, X. Wang · 2019 · Diagnostic and Interventional Imaging
  96. Diagnostic and Prognostic Value of Circulating CircRNAs in Cancer
    Mina Wang, Feiyu Xie, Jiaran Lin, Yihan Zhao, Qian Zhang, Zehuan Liao, Peng Wei · 2021 · Frontiers in Medicine
  97. Single nucleotide polymorphisms (SNPs) in prostate cancer: its implications in diagnostics and therapeutics.
    Khaled S. Allemailem, Ahmad Almatroudi, Faris Alrumaihi, Nahlah Makki Almansour, Fahad M. Aldakheel, Rafiq Ahmad Rather, Dil Afroze, Bilal Rah · 2021 · PubMed Central
  98. Lipid metabolism of cancer stem cells (Review)
    Huihui Liu, Zhengyang Zhang, Lian Song, Jie Gao, Yanfang Liu · 2022 · Oncology Letters
  99. Integrative Ligand-Based Pharmacophore Modeling, Virtual Screening, and Molecular Docking Simulation Approaches Identified Potential Lead Compounds against Pancreatic Cancer by Targeting FAK1
    Mohammad Habibur Rahman Molla, Mohammed Othman Aljahdali, Md Afsar Ahmed Sumon, Amer H. Asseri, Hisham N. Altayb, Md. Shafiqul Islam, Ahad Amer Alsaiari, Firoz A. Dain Md Opo, Nushrat Jahan, Foysal Ahammad et al. · 2023 · Pharmaceuticals
  100. SLC38A5 Modulates Ferroptosis to Overcome Gemcitabine Resistance in Pancreatic Cancer
    Myeong‐Jin Kim, Hyung Sun Kim, Hyeon Woong Kang, Da Eun Lee, Woosol Chris Hong, Ju-Hyun Kim, Min‐Soo Kim, Jae‐Ho Cheong, Hyo Jung Kim, Joon Seong Park · 2023 · Cells